CD2-directed LFA-3/Fc Fusion Protein
- Name
- CD2-directed LFA-3/Fc Fusion Protein
- Accession Number
- DBCAT003999
- Description
-
Not Available
- Drugs
-
Drug Drug Description Alefacept A recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis. - Drugs & Drug Targets
-
Drug Target Type Alefacept T-cell surface antigen CD2 target Alefacept Low affinity immunoglobulin gamma Fc region receptor III-B target Alefacept Low affinity immunoglobulin gamma Fc region receptor III-A target